In silico docking, strong interactions of key phytochemicals, especially quercetin, luteolin, and β‐sitosterol, with NAFLD‐related targets (PPAR‐α, PPAR‐γ, AMPK, and SREBP‐1c), support the mechanistic basis for its efficacy. Here, PPARG is linked to metabolic dysfunction-associated steatotic liver disease.